Business & Investment Opportunities of Psychedelics with Brom Rector

How has the perception of psychedelic medicine evolved over time, and what role does Empath Ventures play in this change?

In this episode, we are joined by Brom Rector, founder of Empath Ventures, a VC fund that invests in early-stage psychedelic medicine companies. Brom shares his experience in finding investors interested in the space and the importance of targeting those who have already experienced the transformative effects of psychedelics. He discusses his personal journey with psychedelics and touches on how psychedelics can be used to treat mental health issues. Brom highlights the potential for real estate professionals to invest in the emerging psychedelic industry and provides resources for learning more about it. Let’s dive in!

[00:01 - 07:12] Opening Segment

• Investing in early-stage psychedelic medicine companies

• Brom introduces Empath Ventures

• Psychedelics as a form of experiential medicine that gives you a perspective shift

• People who have had transformational experiences with psychedelics

[07:13 - 13:41] A Fund Focused on Psychedelic Medicine

• Psychedelic medicine has defining characteristics of an experience and long-lasting benefits

• Investing in both natural and synthetic compounds

• Brom’s personal experience with psychedelics and what led him to start the fund

[13:42 - 20:29] Exploring the Regulatory Landscape and Business Opportunities

• Pharma companies are working on getting psychedelics approved by the FDA through clinical trials.

• How companies are inventing new psychedelic drugs and creating infrastructure and accessories for psychedelic therapy

• How psychedelics can be used to treat depression, anxiety, and PTSD

• Current treatments like SSRIs are not effective for everyone

[20:30 - 27:48] Why Investors Turn to Psychedelics

• Current psychiatric drugs have side effects and often don’t work well

• Anti-anxiety drugs like benzodiazepines can be addictive and don’t solve the root problem

• Psychedelic-assisted therapy is showing promise in treating depression, anxiety, and PTSD

• Investment in the psychedelic industry could redirect funds from ineffective psychiatric drugs

[27:49 - 34:38] The Growing Acceptance and Investment Opportunities in Psychedelics

• Popular media portrayals of psychedelics have helped shift public perception

• Biotech companies are exploring the use of psychedelics for disorders beyond mental health

• Alzheimer’s and stroke recovery

• How retreats and resorts in other countries can be good cashflow-generating businesses

[34:39 - 42:28] Closing Segment

• The opportunities and risks of investing in psychedelics

• Brom shares resources for learning about psychedelics

Want to connect with Brom? Follow him on Twitter. Head Empath Ventures, funding the future of psychedelic medicine!

Resources Mentioned:

How to Change Your Mind - Michael Pollan

Key Quotes:

“My general take on drugs, including alcohol and even caffeine, is that they work better the less frequently you do them. So pace yourself.” - Brom Rector

Download our FREE Strategizing for Inflation Guide here: https://www.excelsiorgp.com/download/

Connect with me on LinkedIn!

LIKE, SUBSCRIBE, AND LEAVE US A REVIEW on Apple Podcasts, Spotify, Google Podcasts, or whatever platform you listen on. Thank you for tuning in, and Stay Tuned for the Next Episode COMING SOON!

Hosted on Acast. See acast.com/privacy for more information.